Blincyto (blinatumomab)

pCPA File Number: 20972
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Lymphoblastic Leukemia
Sponsor/Manufacturer:
Amgen Canada Inc.
CADTH Project Number:
pCODR 10097
pCPA Engagement Letter Issued:
Negotiation Process Concluded: